Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Research Report Goldmine | CICC: Raises Baidu Hong Kong Stock Target Price to HKD 196, Maintains "Outperform" Rating

Research Report Goldmine | CICC: Raises Baidu Hong Kong Stock Target Price to HKD 196, Maintains "Outperform" Rating

格隆汇格隆汇2026/01/09 03:24
Show original
By:格隆汇
Glonghui News, January 9 | CICC published a report stating that on January 6, Baidu announced its autonomous driving platform, Apollo Go, officially received a fully driverless testing permit from the Dubai Roads and Transport Authority, making it the first and currently only platform authorized to conduct fully driverless tests in Dubai. The company expects Apollo Go's fully driverless fleet in Dubai to expand to over 1,000 vehicles. CICC basically maintains its revenue and non-GAAP net profit forecasts for Baidu for 2025/2026 and introduces new forecasts for 2027, with revenue and non-GAAP net profit projected at RMB 135 billion and RMB 22.1 billion, respectively. The bank maintains its “Outperform” industry rating for Baidu and raises the target price for its US and Hong Kong shares by 8.5% and 7%, to USD 205 and HKD 196, respectively.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Record High Monthly Active Users Can't Hide Risks: Pinterest (PINS.US) Q3 Revenue and Profit Both Miss Expectations, Q4 Guidance Weak, Shares Drop Over 10% After Hours

Pinterest (PINS.US), the image-based social networking and shopping platform, released its Q3 2026 financial report on Thursday, October 29 local time. Although global monthly active users (MAU) reached a historic high of 661 million and net sales achieved double-digit growth, both the company's revenue and adjusted profit for the quarter fell short of Wall Street expectations.

智通财经•2026/10/29 23:11

Core business achieves fastest growth in over a decade! Gilead (GILD.US) Q3 is a mix of good and bad news: Raises full-year sales guidance but Biktarvy will face a 38% price cut pressure from U.S. Medicare

On October 29th (Thursday) local time, US biopharmaceutical giant Gilead Sciences (GILD.US) released its financial report for the third quarter of 2026. Driven by double-digit growth in its flagship HIV drug portfolio, the company's product sales in the quarter increased by 13% year-over-year to $8.3 billion, surpassing market expectations.

智通财经•2026/10/29 22:56